Sage Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.69-2.96-7.518.76
Price/Sales ratio
4.081.851.190.77
Earnings per Share (EPS)
$-5.13$-2.93$-1.15$0.99

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-23.35-17.13-10.74-23.23-11.84-5.647.42-5.53-4.49-2.39-4.83-11.84
Price/Sales ratio
N/AN/AN/AN/A48.93534.314.03395.66294.2914.99334.9848.93
Price/Book Value ratio
6.479.324.6313.195.113.882.171.441.801.622.053.88
Price/Cash Flow ratio
-29.19-22.91-14.40-28.61-16.94-6.946.76-6.59-4.91-2.39-5.59-16.94
Price/Free Cash Flow ratio
-29.06-22.84-14.23-28.44-16.76-6.866.77-6.59-4.90-2.39-5.58-16.76
Price/Earnings Growth ratio
-0.53-0.14-0.27-0.47-0.84-0.09-0.030.03-0.42-0.360.32-0.84
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A98.78%94.17%99.94%91.23%89.42%97.50%89.42%94.17%
Operating Profit Margin
N/AN/AN/AN/A-435.60%-10310.48%53.51%-7306.73%-7116.69%-670.69%-7115.75%-7115.75%
Pretax Profit Margin
N/AN/AN/AN/A-413.06%-9904.45%54.39%-7258.90%-6931.87%-626.32%-6930.97%-6930.97%
Net Profit Margin
N/AN/AN/AN/A-413.06%-9466.38%54.39%-7146.90%-6547.84%-626.32%-6930.97%-6930.97%
Effective Tax Rate
0.17%0.31%0.93%1.34%-5.45%4.42%2.56%1.54%5.54%N/AN/A-5.45%
Return on Assets
-26.07%-49.99%-39.30%-50.97%-39.13%-59.96%28.06%-24.69%-37.10%-61.37%-39.27%-59.96%
Return On Equity
-27.74%-54.40%-43.14%-56.81%-43.20%-68.82%29.24%-26.07%-40.17%-67.72%-37.02%-43.20%
Return on Capital Employed
-27.73%-54.48%-43.36%-57.14%-45.37%-72.85%28.49%-26.48%-43.50%-72.52%-43.50%-45.37%
Liquidity Ratios
Current Ratio
16.6012.3111.4410.1010.989.2331.58N/AN/AN/A13.4610.98
Quick Ratio
16.6012.3111.4410.1010.989.2331.5821.3513.4610.4812.9510.98
Cash ratio
16.4712.204.795.892.211.1324.713.451.630.851.631.13
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A1.07K648.69356.36648.61N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A-12.21K-28.95K253.58N/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A-11.14K-28.30K609.95159.93N/A
Days of Payables Outstanding
N/A16.37K16.64K6.82K11.29K13.93K2.38K6.89K8.50K1.74K8.50K13.93K
Cash Conversion Cycle
N/AN/AN/AN/A-11.29K-13.93K-2.38K-18.04K-36.81K-1.13K-7.85K-11.29K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.030.010.010.000.000.070.07
Debt Equity Ratio
N/AN/AN/AN/AN/A0.030.010.010.000.000.080.08
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.020.000.000.00N/A0.000.02
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.030.010.010.000.000.000.03
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-38.54N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-14.2523.63-20.51-37.91-104.66-37.91-14.25
Company Equity Multiplier
1.061.081.091.111.101.141.041.051.081.101.081.14
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-2.88-76.980.59-59.95-59.85-6.25-59.84-59.84
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.011.001.011.010.991.001.001.001.001.01
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-14.2523.63-20.51-37.91-104.66-37.91-14.25
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-51.6176.68-50.64-60.19-104.66-60.19-51.61
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A